Showing results (361-370 of 1,188) with videos related to

Sort By:
Pageof 119
Blood|October 17, 2012
Epigenetic therapy is associated with similar survival compared with intensive chemotherapy in older patients with newly diagnosed acute myeloid leukemiaAlfonso Quintás-Cardama, Farhad Ravandi, Theresa Liu-Dumlao, et al.
Leukemia Research|June 10, 2017
Preclinical activity of FF-10501-01, a novel inosine-5'-monophosphate dehydrogenase inhibitor, in acute myeloid leukemiaHui Yang, Zhihong Fang, Yue Wei, et al.
Blood|October 24, 2002
Dose escalation of imatinib mesylate can overcome resistance to standard-dose therapy in patients with chronic myelogenous leukemiaHagop M Kantarjian, Moshe Talpaz, Susan O'Brien, et al.
Journal of Clinical Psychopharmacology|August 13, 2002
Use of topiramate in treatment-resistant bipolar spectrum disordersEduard Vieta, Carla Torrent, Guillermo Garcia-Ribas, et al.
Contributions to Nephrology|November 14, 2006
Risk of peritonitis among disadvantaged CAPD patients in MexicoGuillermo Garcia-Garcia, Noemi Tachiquín-Bautista, Victor Hugo Luquin-Arellano, et al.
Cancer|November 30, 2006
Update of the decitabine experience in higher risk myelodysplastic syndrome and analysis of prognostic factors associated with outcomeHagop M Kantarjian, Susan O'Brien, Jianqin Shan, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 2, 2014
Acute myeloid leukemia with t(10;11): a pathological entity with distinct clinical presentationCourtney D DiNardo, Guilin Tang, Naveen Pemmaraju, et al.
Cancer|April 17, 2014
Treatment with FLT3 inhibitor in patients with FLT3-mutated acute myeloid leukemia is associated with development of secondary FLT3-tyrosine kinase domain mutationsYesid Alvarado, Hagop M Kantarjian, Rajyalakshmi Luthra, et al.
Leukemia|June 3, 2024
Association between class III obesity and overall survival in previously untreated younger patients with acute myeloid leukemia enrolled on SWOG S1203Michelle Y Zhang, Megan Othus, Kerry McMillen, et al.
Cancer|January 26, 2006
Results of intensive chemotherapy in 998 patients age 65 years or older with acute myeloid leukemia or high-risk myelodysplastic syndrome: predictive prognostic models for outcomeHagop Kantarjian, Susan O'brien, Jorge Cortes, et al.
Pageof 119